Trial · NCT05915286
Registered outcomes33
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 33
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in 24-hour urine output | Week 1 | Change in urine output measured from 24-hour urine collection. |
| Primary | Change in 24-hour urine output | Week 2 | Change in urine output measured from 24-hour urine collection. |
| Primary | Change in 24-hour urine output | Week 3 | Change in urine output measured from 24-hour urine collection. |
| Primary | Change in 24-hour urine output | Week 4 | Change in urine output measured from 24-hour urine collection. |
| Primary | Change in 24-hour urine output | Week 5 | Change in urine output measured from 24-hour urine collection. |
| Primary | Change in residual renal function | Week 1 | Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection. |
| Primary | Change in residual renal function | Week 2 | Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection. |
| Primary | Change in residual renal function | Week 3 | Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection. |
| Primary | Change in residual renal function | Week 4 | Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection. |
| Primary | Change in residual renal function | Week 5 | Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection. |
| Secondary | Interdialytic weight gain | Week 1 | Patient weight measured in kilograms |
| Secondary | Interdialytic weight gain | Week 2 | Patient weight measured in kilograms |
| Secondary | Interdialytic weight gain | Week 3 | Patient weight measured in kilograms |
| Secondary | Interdialytic weight gain | Week 4 | Patient weight measured in kilograms |
| Secondary | Interdialytic weight gain | Week 5 | Patient weight measured in kilograms |
| Secondary | Patient-reported outcomes - ESAS-r | Week 1 | Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire. |
| Secondary | Patient-reported outcomes - ESAS-r | Week 2 | Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire. |
| Secondary | Patient-reported outcomes - ESAS-r | Week 3 | Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire. |
| Secondary | Patient-reported outcomes - ESAS-r | Week 4 | Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire. |
| Secondary | Patient-reported outcomes - ESAS-r | Week 5 | Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05915286/registered